Miyazaki Teru takes the presidency and makes the “healthy loss-making division” the axis of diversification (1961)
The light and the shade of tolerating losses by design
The heart of this decision was not writing off the prospects of the founding fibre business, but deliberately taking on the risk of new ventures on the back of the earning power of the existing one. Refusing to treat losses as the enemy, and going so far as to call the red ink of a new business “healthy” so long as it did not break the company’s finances, was an unusual idea in the management of a large Japanese company at the time. That Miyazaki already felt a sense of crisis in an era of generous dividends and a firm share price is what supported the scale and the speed of the investment that followed.
The method carried a side effect all the same: it blurred the criteria for withdrawal. Positioning the losses of a new business as “healthy” made it hard to draw the line on how long they would be tolerated, and this fed into the low profitability and the delayed disposals that Asahi Kasei Kogyo carried in later years. Given how quickly the shift to selection and concentration proceeded once Miyazaki had died, the decision of 1961 was at once the starting point of Asahi Kasei Kogyo as a diversified company and the judgment that sowed the problem it would spend decades facing.
Read the full dossier in Japanese →
The Japanese edition carries the complete record of this decision — the situation that forced it, the options weighed, what actually followed, and the sources behind every claim.
Other key decisions at Asahi Kasei
- 1946 Splitting from the Nichitsu konzern to become Asahi Kasei Kogyo (1946)
- 1968 The ¥100 billion petrochemical complex at Mizushima — a sum equal to a year of sales (1968)
- 1972 Turning the ALC building material Hebel into a housing brand (1972)
- 1985 Yoshino Akira fixes the basic structure of the lithium-ion battery, and the patents that follow (1985)
- 1993 Turning away from “expansion”: selling the food and liquor businesses (1993)
- 2012 Buying ZOLL Medical for $2.21 billion and entering critical care (2012)
Yen amounts are converted at the average rate of each figure’s own year — not today’s rate; the revenue chart is shown in yen. Exchange rates & sources — the full ¥/US$ table →
Disclaimer
- This page is provided for general information only and is not investment advice, nor a recommendation to buy or sell any security.
- Figures are compiled independently and include our own estimates, approximations and machine-processed data; we make no warranty as to their accuracy or completeness.
- Sources are primarily each company’s securities reports and other public filings, but errors and omissions may remain.
- Any use of this information is at the reader’s own risk. Past performance does not indicate future results.
- Company names, logos and other marks belong to their respective owners.
Data API
Asahi Kasei’s history, financials, executives and
shareholders are published as static JSON — no key, plain GET.
Full specification →
| Method | Endpoint | Returns |
|---|---|---|
| GET | /api/companies.json | All companies |
| GET | /api/3407/manifest.json | Resource index |
| GET | /api/3407/history.json | History overview |
| GET | /api/3407/timeline.json | Chronology |
| GET | /api/decisions.json | All management decisions (index) |
| GET | /api/3407/decisions.json | Management decisions (index) |
| GET | /api/3407/decisions/{slug}.json | One decision (full dossier) |
| GET | /api/3407/executives.json | Executives |
| GET | /api/3407/shareholders.json | Major shareholders |
| GET | /api/3407/financials.json | Financial statements |
| GET | /api/3407/financials-longterm.json | Long-term results |
| GET | /api/3407/segments.json | Business segments |
| GET | /api/3407/regions.json | Sales by region |
| GET | /api/3407/workforce.json | Workforce |